Search Within

Marcel R M Van Den Brink

  1. "Nancy Kernan"
Formats
  1. Meeting Abstract (37)
  2. Journal Article (17)
Groups
  1. Bone Marrow Transplant (54)
  2. Center for Hematologic Malignancies (54)
  3. Department of Medicine (54)
  4. Executive Committee, Center for Hematologic Malignancies (54)
  5. GSK Faculty (54)
  6. Hematologic Malignancies, Division of (54)

More Groups

People
  1. Nancy Kernan (54)
  2. James Young (51)
  3. Richard O'Reilly (48)
  4. Miguel-Angel Perales (46)
  5. Esperanza Papadopoulos (45)
  6. Ann Jakubowski (44)

More People

Years
  1. 2020 (2)
  2. 2018 (1)
  3. 2017 (3)
  4. 2015 (5)
  5. 2014 (3)
  6. 2013 (5)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (26)
  2. Blood (25)
  3. Bone Marrow Transplantation (2)
  4. Leukemia and Lymphoma (1)
Publishers
  1. Elsevier Inc. (26)
  2. American Society of Hematology (25)
  3. Nature Publishing Group (2)
  4. Taylor & Francis Group (1)

Results (54)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Host T-cells contribute to immune reconstitution and improved outcome in recipients of CD34 selected T-cell depleted allografts (TCD HCT) with full hematopoietic cell but persistent mixed T-cell chimerism
    Meeting Abstract

    O'Reilly, R. J.; Koehne, G.; Heller, G.; Boulad, F.; Castro-Malaspina, H.; Giralt, S. A.; Jakubowski, A. A.; Kernan, N. A.; Papadopoulos, E. B.; Perales, M.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Outcomes of two chemotherapy-based preparatory regimens compared to tbi-based conditioning when used with CD34(+) selected T-cell depleted alloHCT for high risk hematologic malignancies: Prospective clinical trial NCT 01119066
    Meeting Abstract

    O'Reilly, R. J.; Koehne, G.; Boulad, F.; Heller, G.; Klein, E.; Barker, J. N.; Castro-Malaspina, H.; Curran, K. J.; Hsu, K. C.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Evaluation of cord blood (CB) unit TNC & CD34+ cell content & donor-recipient high-resolution 8 HLA-allele match by patient ancestry: An evaluation of 513 CB units in a racially & ethnically diverse population of adults with hematologic malignancies
    Meeting Abstract

    Mazis, C.; Politikos, I.; Devlin, S. M.; Maloy, M.; Davis, E.; Cooper, C.; Nhaissi, M.; Suri, B.; Wells, D.; Giralt, S.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • A chemotherapy-only regimen of busulfan, melphalan, and fludarabine, and rabbit antithymocyte globulin followed by allogeneic T-cell depleted hematopoietic stem cell transplantations for the treatment of myeloid malignancies
    Journal Article

    Spitzer, B.; Jakubowski, A. A.; Papadopoulos, E. B.; Fuller, K.; Hilden, P. D.; Young, J. W.; Barker, J. N.; Koehne, G.; Perales, M. A.; Hsu, K. C.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Early recovery of T-cell function predicts improved survival after T-cell depleted allogeneic transplant
    Journal Article

    Goldberg, J. D.; Zheng, J.; Ratan, R.; Small, T. N.; Lai, K. C.; Boulad, F.; Castro-Malaspina, H.; Giralt, S. A.; Jakubowski, A. A.; Kernan, N. A.; more...
    Leukemia and Lymphoma (2017)

    Fulltext@MSK | Save
  • Ex vivo CD34(+)–selected T cell–depleted peripheral blood stem cell grafts for allogeneic hematopoietic stem cell transplantation in acute leukemia and myelodysplastic syndrome is associated with low incidence of acute and chronic graft-versus-host disease and high treatment response
    Journal Article

    Barba, P.; Hilden, P.; Devlin, S. M.; Maloy, M.; Dierov, D.; Nieves, J.; Garrett, M. D.; Sogani, J.; Cho, C.; Barker, J. N.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • High disease-free survival with enhanced protection against relapse after double-unit cord blood transplantation when compared with T cell-depleted unrelated donor transplantation in patients with acute leukemia and chronic myelogenous leukemia
    Journal Article

    Ponce, D. M.; Hilden, P.; Devlin, S. M.; Maloy, M.; Lubin, M.; Castro-Malaspina, H.; Dahi, P.; Hsu, K.; Jakubowski, A. A.; Kernan, N. A.; more...
    Biology of Blood and Marrow Transplantation (2015)

    Fulltext@MSK | Save
  • Two chemotherapy-based conditioning regimens compared to TBI-based conditioning secure consistent engraftment of T-cell depleted allogeneic HSCT, similarly low incidences of GVHD and favorable rates of disease-free survival (DFS)
    Meeting Abstract

    Koehne, G.; Boulad, F.; Barker, J.; Castro-Malaspina, H.; Curran, K.; Giralt, S.; Hasan, A.; Heller, G.; Hsu, K.; Jakubowski, A.; more...
    Bone Marrow Transplantation (2015)

    Fulltext@MSK | Save
  • Intensified mycophenolate mofetil dosing and higher mycophenolic acid trough levels reduce severe acute graft-versus-host disease after double-unit cord blood transplantation
    Journal Article

    Harnicar, S.; Ponce, D. M.; Hilden, P.; Zheng, J.; Devlin, S. M.; Lubin, M.; Pozotrigo, M.; Mathew, S.; Adel, N.; Kernan, N. A.; more...
    Biology of Blood and Marrow Transplantation (2015)

    Fulltext@MSK | Save
  • In landmark analysis the severity of day 100 acute graft-versus-host disease (aGVHD) has no impact on long-term progression-free survival (PFS) after double-unit cord blood transplantation (DCBT)
    Meeting Abstract

    Ponce, D. M.; Devlin, S.; Bhatt, V.; Pozotrigo, M.; Lubin, M.; Lauer, E.; Kernan, N. A.; Scaradavou, A.; Hanash, A. M.; Perales, M. A.; more...
    Biology of Blood and Marrow Transplantation (2015)

    Fulltext@MSK | Save